1. Market Research
  2. > Pharmaceutical Market Trends
  3. > Moldova Pharmaceuticals and Healthcare Report Q4 2016

Moldova Pharmaceuticals and Healthcare Report Q4 2016

  • September 2016
  • -
  • Business Monitor International
  • -
  • 71 pages

Includes 3 FREE quarterly updates


BMI View: Moldova's pharmaceutical market presents very limited opportunities for multinational drugmakers, in comparison to its neighbours in Eastern Europe. The country's small total market size and its reliance on out-of-pocket payments highlight the challenges it poses. Moreover, continued economic weakness and negative demographic trends will limit growth prospects.

Headline Expenditure Projections
- Pharmaceuticals: MDL5.83bn (USD310mn) in 2015 to MDL6.23bn (USD322mn) in 2016; 6.7% in local currency terms and 3.8% in US dollar terms. Forecast unchanged from previous quarter.
- Healthcare: MDL12.32bn (USD654mn) in 2015 to MDL13.27bn (USD686mn) in 2015; +7.7% in local currency terms and 4.8% in US dollar terms. Forecast unchanged from previous quarter.

Table Of Contents

Moldova Pharmaceuticals and Healthcare Report Q4 2016
BMI Industry View 7
Table: Headline Pharmaceuticals and Healthcare Forecasts (Moldova 2014-2020) 7
SWOT 9
Industry Forecast 11
Pharmaceutical Market Forecast 11
Table: Pharmaceutical Sales, Historical Data And Forecasts (Moldova 2012-2020) 13
Healthcare Market Forecast 14
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Moldova 2012-2020) 16
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Moldova 2012-2020) 16
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Moldova 2012-2020) 17
Prescription Drug Market Forecast 18
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Moldova 2012-2020) 20
Patented Drug Market Forecast 21
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Moldova 2012-2020) 22
Generic Drug Market Forecast 23
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Moldova 2012-2020) 24
OTC Drug Market Forecast 25
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Moldova 2012-2020) 26
Pharmaceutical Trade Forecast 27
Table: Pharmaceutical Trade Data And Forecasts (Moldova 2014-2020) 28
Table: Pharmaceutical Trade Data And Forecasts local currency (Moldova 2014-2020) 29
Industry Risk Reward Index 30
Central And Eastern Europe Risk/Reward Index - Q4 2016 30
Moldova Risk/Reward Index 37
Rewards 37
Risks 38
Regulatory Review 39
Intellectual Property Issues 41
Pricing Regime 42
Reimbursement Regime 43
Market Overview 45
Healthcare Sector 46
Research And Development 49
Clinical Trials 49
Epidemiology 50
Competitive Landscape 53
Research-Based Industry 53
Table: Multinational Market Activity 55
Pharmaceutical Distribution 55
Pharmaceutical Retail Sector 57
Company Profile 58
Farmaco (Pharmaco) 58
Demographic Forecast 60
Table: Population Headline Indicators (Moldova 1990-2025) 61
Table: Key Population Ratios (Moldova 1990-2025) 61
Table: Urban/Rural Population and Life Expectancy (Moldova 1990-2025) 62
Table: Population By Age Group (Moldova 1990-2025) 62
Table: Population By Age Group % (Moldova 1990-2025) 63
Glossary 65
Methodology 67
Pharmaceutical Expenditure Forecast Model 67
Healthcare Expenditure Forecast Model 67
Notes On Methodology 68
Risk/Reward Index Methodology 69
Index Overview 70
Table: Pharmaceutical Risk/Reward Index Indicators 70
Indicator Weightings 71

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Prostate Cancer Pricing, Reimbursement, and Access

Prostate Cancer Pricing, Reimbursement, and Access

  • $ 7 500
  • Industry report
  • July 2016
  • by Datamonitor Healthcare

Novel antiandrogens will need to present risk-sharing agreements in EU markets, while discussing contracting with US payers to ensure a competitive advantage. Vaccines suffer from inconclusive response ...

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

  • $ 7 000
  • Industry report
  • August 2016
  • by Frost & Sullivan

Emerging Business Models Drive Transformation The key objective of this research is to provide in-depth knowledge of the major global pharmaceutical CMO market segments—active pharmaceutical ingredients ...

IMS World Review Executive™ 2016

IMS World Review Executive™ 2016

  • $ 6 860
  • Industry report
  • July 2016
  • by IMS Health

IMS World Review ExecutiveTM 2016 provides essential insights into worldwide sales of the pharmaceutical market, interlocking market trends and sales analysis from 2011 to 2015, including the breakdown ...


ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.